Quick Takeaways
- Joshua Silverman has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,268,991.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Joshua Silverman
- Location
- New York, NY
- Summary
- The estimated net worth of Joshua Silverman is at least $2,268,991 dollars as of 15 Apr 2026. Joshua Silverman is the Executive Chairman, Director of Q/C TECHNOLOGIES, INC. and owns shares of Q/C TECHNOLOGIES, INC. (QCLS) stock worth about $1.05M. Joshua Silverman is the Executive Chairman, Director of TAO Synergies Inc. and owns shares of TAO Synergies Inc. (TAOX) stock worth about $626.7K. Joshua Silverman is the CEO and President, Director of PharmaCyte Biotech, Inc. and owns shares of PharmaCyte Biotech, Inc. (PMCB) stock worth about $397.7K. Joshua Silverman is the Chief Executive Officer, Director of StableX Technologies, Inc. and owns shares of StableX Technologies, Inc. (SBLX) stock worth about $154.3K. Joshua Silverman is the Director of Petros Pharmaceuticals, Inc. and owns shares of Petros Pharmaceuticals, Inc. (PTPI) stock worth about $44.2K.
- Signature
- /s/ Joshua Silverman
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Joshua Silverman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Q/C TECHNOLOGIES, INC. ($1,046,142).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Joshua Silverman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QCLS | Q/C TECHNOLOGIES, INC. | Executive Chairman, Director | $1,046,142 | 13 Apr 2026 | ||
| TAOX | TAO Synergies Inc. | Executive Chairman, Director | $626,703 | 06 Aug 2025 | ||
| PMCB | PharmaCyte Biotech, Inc. | CEO and President, Director | $397,694 | +$80,476 | +25% | 05 Jan 2026 |
| SBLX | StableX Technologies, Inc. | Chief Executive Officer, Director | $154,298 | 31 Oct 2025 | ||
| PTPI | Petros Pharmaceuticals, Inc. | Director | $44,154 | 02 Jan 2026 | ||
| FEMY | FEMASYS INC | Director | 17 Mar 2026 |
Insider Transactions Reported by Joshua Silverman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.